Concepedia

Peggy Guzzie‐Peck

PG

Statistics

Publications

4

Citations

213

H-Index

4

Active since

2012

Affiliations

Janssen (United States)(Current)

AstraZeneca (United Kingdom)

Sanofi (United States)

AstraZeneca (United States)

Bristol-Myers Squibb (United States)

Peggy Guzzie‐Peck is an author at Janssen (United States) specializing in early drug discovery, pharmacology, and pharmacy.

Publications per year

2012–2017

4

Publications

4

Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective

Lorna Ewart, Kristin Fabre, Ananthsrinivas Chakilam et al. · Experimental Biology and Medicine · 2017 · 87 citations · Full text

Engineering, Biomedical Engineering, Biotechnology +13

Evaluation of miR-122 and Other Biomarkers in Distinct Acute Liver Injury in Rats

Sofie Starckx, Ameesha Batheja, Geert R. Verheyen et al. · Toxicologic Pathology · 2012 · 67 citations

Pharmacy, Pharmacology, Toxicology +17

Current nonclinical testing paradigms in support of safe clinical trials: An IQ Consortium DruSafe perspective

Lynne Butler, Peggy Guzzie‐Peck, James Hartke et al. · Regulatory Toxicology and Pharmacology · 2017 · 44 citations

Public Health, Biostatistics, Clinical Research Regulation +11

Regulatory Forum Opinion Piece <sup>*</sup> : Use and Utility of Animal Models of Disease for Nonclinical Safety Assessment: A Pharmaceutical Industry Survey

Sherry J. Morgan, Jessica A. Couch, Peggy Guzzie‐Peck et al. · Toxicologic Pathology · 2017 · 15 citations

Pharmacy, Pharmacology, Toxicology +16

1–4 of 4